RGNX
Regenxbio·NASDAQ
--
--(--)
--
--(--)
7.87 / 10
Outperform
Analyst coverage shows 1 Strong Buy and 1 Buy, weighted rating 8.14, and sentiment score 7.87. Fund‑flow score is 7.6 (good) with positive inflows in Medium and Large blocks but negatives elsewhere, reinforcing a generally bullish outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-06
InstitutionMorgan Stanley
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for RGNX?
- RGNX holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.87/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
